Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics

Abstract

Jian-Gan-Xiao-Zhi decoction (JGXZ) has demonstrated beneficial effects on nonalcoholic fatty liver disease (NAFLD). However, the mechanisms by which JGXZ improve NAFLD are still unclear. Methods. In this study, we first used a high-fat diet (HFD) to establish a NAFLD rat model to clarify the therapeutic effect of JGXZ on NAFLD. Secondly, we used network pharmacology to predict the potential targets of JGXZ on NAFLD, and then the key targets obtained from network pharmacology were verified. Finally, we used untargeted metabolomics to study the metabolic regulatory mechanism of JGXZ. Results. JGXZ treatment could decrease body weight and ameliorate dyslipidemia in NAFLD model rats. H&E and oil red O staining indicated that JGXZ reduced steatosis and infiltration of inflammatory cells in the liver. In addition, network pharmacology research found that the potential targets of JGXZ on NAFLD pathway were mainly associated with improving oxidative stress, apoptosis, inflammation, lipid metabolism disorders, and insulin resistance. Further experimental verification confirmed that JGXZ could inhibit inflammation and improve oxidative stress, insulin resistance, and lipid metabolism disorders. Serum untargeted metabolomics analyses indicated that the JGXZ in the treatment of NAFLD may work through the linoleic acid metabolism, alpha-linolenic acid metabolism, tryptophan metabolism, and glycerophospholipid metabolism pathways. Conclusions. In conclusion, this study found that JGXZ has an ameliorative effect on NAFLD, and JGXZ alleviates the inflammatory response and oxidative stress and lipid metabolism disorders in NAFLD rats. The mechanism of action of JGXZ in the treatment of NAFLD may be related to the regulation of linoleic acid metabolism, tryptophan metabolism, alpha-linolenic acid metabolism, and glycerophospholipid metabolism.

The effect of lipid metabolism disorder on the immune microenvironment in Xinjiang patients with hyperuricemia using Multi-Omics analysis

“…The aforementioned ndings indicate that a signi cant proportion of glycerol phospholipids and their metabolites were altered in the blood of individuals with HUA, and the disturbance of phospholipid metabolism mainly involves phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylcholine (PC), phosphatidylserine (PS), lysophosphatidylinositol (LPI). These lipid molecules can participate in bio lm formation, cell membrane recognition, and signal transduction [19] . For example, UA can activate LPCs, allowing UA to activate phospholipid remodeling enzyme LPCAT3 in vivo and in vitro and nally catalyze the generation of PCs [18,20] .…”

Deciphering the mechanism of jujube vinegar on hyperlipoidemia through gut microbiome based on 16S rRNA, BugBase analysis, and the stamp analysis of KEEG

“…SOD can catalyze superoxide into oxygen and hydrogen peroxide (H2O2) (33). GSH-Px catalyzes the conversion of reduced GSH to oxidized glutathione, protecting cells from disruption and damage caused by peroxide (34). MDA is the last product of lipid peroxidation, and it is an important indicator of body's oxidative stress levels (35).…”

The effect of lipid metabolism disorder on patients with hyperuricemia using Multi-Omics analysis

“…In addition to forming biofilms and recognizing cell membranes, these lipid molecules play a key role in signal transduction as well 21 . The LPCs can be activated by UA, and recombinant lyso-phosphatidylcholine acyltransferase-3 (LPCAT3) can be activated in vitro and in vivo, catalyzing PC generation 19 , 22 . This indicated that uric acid participates in metabolism and biosynthesis.…”